Summary & Overview
CPT 27634: Excision of Deep Soft-Tissue Tumor, Leg/Ankle ≥5 cm
CPT code 27634 identifies the surgical excision of a deep soft-tissue tumor located beneath the fascia or within muscle of the leg or ankle when the lesion measures 5 cm or greater in diameter. This code captures a higher-complexity outpatient or inpatient surgical oncology procedure and is relevant for reimbursement, utilization monitoring, and clinical documentation across US payers. Nationally, accurate use of this code affects claims processing, surgical quality reporting, and cost measurement for care of sizable lower-extremity tumors.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna, UnitedHealthcare, and Medicare. Readers will find context on clinical indications for coding this procedure, common sites of service, and how this code maps to surgical oncology workflows. The publication outlines benchmarks for coding prevalence and allowed amounts where available, summarizes recent policy considerations that affect coverage and documentation, and highlights clinical factors—tumor size and depth—that determine assignment of this CPT code. Practical guidance on documentation elements needed to support the code and common billing considerations are described at a national level. Data not available in the input has been noted where applicable.
Billing Code Overview
CPT code 27634 describes the surgical excision of a tumor located beneath the fascia or within the muscle of the leg or ankle, where the procedure removes the tumor measuring 5 cm or greater in diameter without taking a significant amount of surrounding normal tissue. This is a surgical oncology procedure focused on deep soft-tissue masses of the lower extremity.
Service type: Operative surgical excision, deep soft tissue tumor removal
Typical site of service: Hospital operating room or ambulatory surgical center
Clinical & Coding Specifications
Clinical Context
A 58-year-old patient presents with a progressively enlarging deep soft-tissue mass in the posterior compartment of the lower leg. Imaging with MRI demonstrates a well-circumscribed intramuscular tumor measuring 6.2 cm in greatest diameter, beneath the fascia and within the gastrocnemius muscle, without radiographic involvement of adjacent neurovascular bundles. The orthopedic oncology or surgical oncology team schedules an operative excision under general anesthesia. Preoperative workflow includes history and physical, informed consent discussing risks of bleeding, infection, nerve injury, and potential need for wider resection if malignancy is suspected, preoperative labs, and MRI review. Intraoperative steps include patient positioning, limb prep and drape, an incision over the lesion, dissection through subcutaneous tissue to the fascia, careful entry into the muscle compartment, tumor identification and marginal excision without removal of a significant amount of surrounding normal tissue, hemostasis, possible placement of drains, layered closure, and specimen submission to pathology. Postoperative workflow includes recovery unit monitoring, analgesia, wound care instructions, pathology follow-up for size and margin assessment, and coordinated outpatient follow-up for wound check and oncologic management if indicated. Typical site of service is an ambulatory surgical center or hospital outpatient surgery unit. Service type is operative excision of an intramuscular soft-tissue tumor of the leg/ankle, size ≥5 cm, corresponding to 27634.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|